Edwards Lifesciences has received CE marking for its transfemoral transcatheter mitral valve replacement system, setting up ...

D printing skin, bone, and even working organs could change transplant medicine and medical research — but how, exactly, does ...

Imricor Medical Systems, Inc. (Company or Imricor) is pleased to announce that it has commenced the VISABL-VT clinical trial by completing the first-in-human ventricular ablation guided by real-time ...

To create a more durable heart valve, Edwards developed the RESILIA tissue technology more than two decades ago. Today, RESILIA tissue is used in a wide range of Edwards’ surgical and transcatheter ...

Learn more about whether LeMaitre Vascular, Inc. or PROCEPT BioRobotics Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The artificial creation of human skin, tissue and internal organs ... will involve constructing parts such as valves, blood vessels and a mini-heart. The company hopes that by using the patient ...

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

Edwards Lifesciences (NYSE: EW) today announced eight-year data highlighting positive long-term outcomes with its proprietary ...